dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dimetyylifumaraatti - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
methylphenidate mylan 18 mg depottabletti
mylan ab - methylphenidate hydrochloride - depottabletti - 18 mg - metyylifenidaatti
methylphenidate mylan 36 mg depottabletti
mylan ab - methylphenidate hydrochloride - depottabletti - 36 mg - metyylifenidaatti
methylphenidate mylan 54 mg depottabletti
mylan ab - methylphenidate hydrochloride - depottabletti - 54 mg - metyylifenidaatti
methylphenidate mylan 27 mg depottabletti
mylan ab - methylphenidate hydrochloride - depottabletti - 27 mg - metyylifenidaatti
dimethyl fumarate teva
teva gmbh - dimetyylifumaraatti - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressantit - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
methylphenidate orion 18 mg depottabletti
orion corporation - methylphenidate hydrochloride - depottabletti - 18 mg - metyylifenidaatti
methylphenidate orion 54 mg depottabletti
orion corporation - methylphenidate hydrochloride - depottabletti - 54 mg - metyylifenidaatti
methylphenidate stada 54 mg depottabletti
stada arzneimittel ag - methylphenidate hydrochloride - depottabletti - 54 mg - metyylifenidaatti
methylphenidate stada 36 mg depottabletti
stada arzneimittel ag - methylphenidate hydrochloride - depottabletti - 36 mg - metyylifenidaatti